News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ViRexx Medical Corp. Announces Change In Board And 13D Filing
February 16, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
EDMONTON, ALBERTA -- (MARKET WIRE) -- February 16, 2007 -- ViRexx Medical Corp. ('ViRexx")(TSX: VIR)(AMEX: REX), announced today effective February 15, 2007, Michael Marcus of Austin, Texas, resigned from the Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Cancer
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
September 1, 2026
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Cellares trims workforce again, laying off 68 in New Jersey
September 1, 2026
·
87 min read
·
BioSpace Editorial Staff
Layoffs
ArsenalBio sacrifices ‘majority’ of staff in pivot to in vivo CAR T
September 1, 2026
·
1 min read
·
Tristan Manalac
Legal
Biomarin nabs big royalties in achondroplasia patent settlement with Ascendis
August 31, 2026
·
2 min read
·
Annalee Armstrong
